---
title: Complete responses in AL amyloidosis are unequal - the impact of free light
  chain mass spectrometry in AL amyloidosis
date: '2024-01-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38194690/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240110170437&v=2.18.0
source: Blood
description: Amyloidogenic serum free light chains (sFLC) drive disease progression
  in AL amyloidosis. Matrix-assisted laser desorption/ionization-time of flight mass
  spectrometry-based free light chain assay (FLC-MS) has greater sensitivity than
  conventional sFLC assays allowing for the detection of serological residual disease.
  We report the utility of FLC-MS in a large series of patients with AL amyloidosis
  assessing the impact of FLC-MS negativity after treatment on overall survival and
  organ ...
disable_comments: true
---
Amyloidogenic serum free light chains (sFLC) drive disease progression in AL amyloidosis. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry-based free light chain assay (FLC-MS) has greater sensitivity than conventional sFLC assays allowing for the detection of serological residual disease. We report the utility of FLC-MS in a large series of patients with AL amyloidosis assessing the impact of FLC-MS negativity after treatment on overall survival and organ ...